STOCK TITAN

Aramark US Financials

ARMK
Source SEC Filings (10-K/10-Q) Updated Apr 3, 2026 Currency USD FYE October

This page shows Aramark US (ARMK) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ARMK FY2025

Thin-margin scale still generates cash, but debt service and steady reinvestment keep the economics tighter than revenue suggests.

Cash conversion is stronger than headline earnings imply: operating cash flow was $727M in FY2024 and $921M in FY2025, both comfortably above net income. With net income only $263M and $326M across those same years, the spread points to a business whose reported profit is compressed by financing and noncash charges even when operating cash is steadier.

This is a scale-driven, low-spread operating model: FY2025 operating margin was only 4.3%, so incremental efficiency matters more than dramatic margin expansion. After $489M of capital spending, free cash flow was $432M, showing that even healthy operating cash must first replenish the asset base before it becomes flexible capital.

Near-term liquidity improved as the current ratio moved from 0.8x in FY2024 to 1.3x in FY2025, which reduces immediate balance-sheet strain. But leverage still ended FY2025 at 1.9x debt-to-equity, meaning the company is easier to fund month to month than it is lightly financed overall.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 38 / 100
Financial Profile 38/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Aramark US's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
31

Aramark US has an operating margin of 4.3%, meaning the company retains $4 of operating profit per $100 of revenue. This results in a moderate score of 31/100, indicating healthy but not exceptional operating efficiency. This is up from 4.1% the prior year.

Growth
45

Aramark US's revenue grew 6.4% year-over-year to $18.5B, a solid pace of expansion. This earns a growth score of 45/100.

Leverage
63

Aramark US has a moderate D/E ratio of 1.94. This balance of debt and equity financing earns a leverage score of 63/100.

Liquidity
21

Aramark US's current ratio of 1.27 is below the typical benchmark, resulting in a score of 21/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
30

Aramark US has a free cash flow margin of 2.3%, earning a moderate score of 30/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
36

Aramark US's ROE of 10.2% shows moderate profitability relative to equity, earning a score of 36/100. This is up from 8.6% the prior year.

Altman Z-Score Grey Zone
2.46

Aramark US scores 2.46, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Strong
7/9

Aramark US passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
2.82x

For every $1 of reported earnings, Aramark US generates $2.82 in operating cash flow ($921.0M OCF vs $326.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate
2.2x

Aramark US earns $2.2 in operating income for every $1 of interest expense ($791.8M vs $364.4M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$18.5B
YoY+6.4%
5Y CAGR+7.6%
10Y CAGR+2.6%

Aramark US generated $18.5B in revenue in fiscal year 2025. This represents an increase of 6.4% from the prior year.

EBITDA
$1.3B
YoY+11.0%
5Y CAGR+30.9%
10Y CAGR+1.1%

Aramark US's EBITDA was $1.3B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 11.0% from the prior year.

Net Income
$326.4M
YoY+24.3%
10Y CAGR+3.3%

Aramark US reported $326.4M in net income in fiscal year 2025. This represents an increase of 24.3% from the prior year.

EPS (Diluted)
$1.22
YoY+23.2%
10Y CAGR+2.4%

Aramark US earned $1.22 per diluted share (EPS) in fiscal year 2025. This represents an increase of 23.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$431.8M
YoY+44.4%
10Y CAGR+4.5%

Aramark US generated $431.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 44.4% from the prior year.

Cash & Debt
$439.6M
YoY-34.6%
5Y CAGR-17.7%
10Y CAGR+14.3%

Aramark US held $439.6M in cash against $6.2B in long-term debt as of fiscal year 2025.

Dividends Per Share
$0.42
YoY+10.5%
5Y CAGR-0.9%

Aramark US paid $0.42 per share in dividends in fiscal year 2025. This represents an increase of 10.5% from the prior year.

Shares Outstanding
263M
YoY-0.4%
5Y CAGR+0.7%
10Y CAGR+0.8%

Aramark US had 263M shares outstanding in fiscal year 2025. This represents a decrease of 0.4% from the prior year.

Margins & Returns

Gross Margin
8.4%
YoY+0.2pp
5Y CAGR+1.8pp
10Y CAGR-1.8pp

Aramark US's gross margin was 8.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the prior year.

Operating Margin
4.3%
YoY+0.2pp
5Y CAGR+6.3pp
10Y CAGR-0.1pp

Aramark US's operating margin was 4.3% in fiscal year 2025, reflecting core business profitability. This is up 0.2 percentage points from the prior year.

Net Margin
1.8%
YoY+0.3pp
5Y CAGR+5.4pp
10Y CAGR+0.1pp

Aramark US's net profit margin was 1.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.3 percentage points from the prior year.

Return on Equity
10.2%
YoY+1.5pp
5Y CAGR+27.4pp
10Y CAGR-1.8pp

Aramark US's ROE was 10.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.5 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$169.8M
YoY+1079.8%
5Y CAGR+91.8%
10Y CAGR+13.0%

Aramark US spent $169.8M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 1079.8% from the prior year.

Capital Expenditures
$489.2M
YoY+14.5%
5Y CAGR+3.2%
10Y CAGR-0.7%

Aramark US invested $489.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 14.5% from the prior year.

ARMK Income Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Revenue $4.9B+1.6% $4.8B-4.3% $5.0B+9.1% $4.6B+8.1% $4.3B-6.0% $4.6B+3.1% $4.4B+0.9% $4.4B
Cost of Revenue $4.5B+1.5% $4.4B-4.7% $4.6B+8.8% $4.3B+8.6% $3.9B-5.6% $4.2B+3.3% $4.0B-0.5% $4.0B
Gross Profit $426.4M+2.5% $416.2M0.0% $416.0M+12.4% $370.1M+2.9% $359.6M-10.3% $400.9M+1.0% $397.0M+18.4% $335.2M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $74.5M+2.5% $72.7M-1.7% $73.9M+12.5% $65.7M-4.0% $68.4M-2.8% $70.4M+7.5% $65.5M+0.1% $65.4M
Operating Income $219.7M+1.0% $217.5M-0.1% $217.8M+19.3% $182.6M+4.8% $174.2M-19.8% $217.3M-0.7% $218.8M+35.3% $161.7M
Interest Expense $1.1M N/A N/A N/A N/A N/A $106.8M+31.0% $81.5M
Income Tax $35.4M-9.6% $39.1M+85.5% $21.1M-12.9% $24.2M+7.7% $22.5M-37.1% $35.8M-4.2% $37.3M+69.0% $22.1M
Net Income $102.0M+6.0% $96.2M+10.4% $87.1M+21.4% $71.8M+16.1% $61.9M-41.4% $105.6M-13.7% $122.4M+110.6% $58.1M
EPS (Diluted) $0.38+5.6% $0.36 N/A $0.27+17.4% $0.23-41.0% $0.39 N/A $0.22

ARMK Balance Sheet

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Total Assets $13.8B+2.2% $13.5B+1.8% $13.3B+0.2% $13.3B-1.5% $13.5B+6.2% $12.7B+0.3% $12.7B+1.0% $12.5B
Current Assets $3.7B+3.1% $3.6B+3.1% $3.5B-0.2% $3.5B-8.1% $3.8B+16.5% $3.3B-3.3% $3.4B+2.3% $3.3B
Cash & Equivalents $475.7M+8.2% $439.6M-31.2% $639.1M+27.4% $501.5M-45.5% $920.5M+90.1% $484.1M-28.0% $672.5M+54.2% $436.1M
Inventory $453.3M+9.3% $414.6M-1.0% $418.8M+6.2% $394.2M-2.9% $405.9M+10.7% $366.7M-5.4% $387.6M+4.6% $370.4M
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill $5.0B+1.8% $4.9B+0.4% $4.9B+0.5% $4.9B+0.9% $4.8B+2.0% $4.7B+0.8% $4.7B+0.8% $4.6B
Total Liabilities $10.6B+2.2% $10.3B+1.8% $10.2B-0.4% $10.2B-2.6% $10.5B+8.8% $9.6B-0.1% $9.6B+0.3% $9.6B
Current Liabilities $3.1B+8.2% $2.9B-19.5% $3.5B+29.5% $2.7B-14.0% $3.2B-9.0% $3.5B-17.0% $4.2B+22.0% $3.5B
Long-Term Debt $6.1B-2.5% $6.2B+15.6% $5.4B-14.1% $6.3B+2.4% $6.1B+22.7% $5.0B+15.6% $4.3B-14.4% $5.0B
Total Equity $3.3B+2.3% $3.2B+1.9% $3.1B+2.1% $3.1B+2.1% $3.0B-2.0% $3.1B+1.4% $3.0B+3.2% $2.9B
Retained Earnings $586.3M+13.7% $515.8M+13.8% $453.3M+15.1% $393.7M+12.7% $349.5M+10.8% $315.5M+31.6% $239.7M+66.4% $144.0M

ARMK Cash Flow Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Operating Cash Flow $400.3M+151.2% -$782.2M-166.5% $1.2B+1433.1% $76.7M-70.0% $255.9M+143.6% -$587.2M-157.5% $1.0B+626.1% $140.7M
Capital Expenditures $101.3M-17.1% $122.2M-14.1% $142.2M+27.7% $111.4M-3.8% $115.8M-3.4% $119.9M-13.9% $139.3M+63.6% $85.1M
Free Cash Flow $299.0M+133.1% -$904.4M-187.5% $1.0B+3077.9% -$34.7M-124.8% $140.1M+119.8% -$707.0M-180.1% $882.3M+1487.4% $55.6M
Investing Cash Flow -$162.8M-5.9% -$153.7M N/A -$131.7M+47.7% -$251.6M-9.0% -$230.8M N/A -$89.6M
Financing Cash Flow -$203.2M-127.6% $735.7M N/A -$387.2M-191.3% $423.9M-34.0% $642.7M N/A $32.4M
Dividends Paid $31.5M0.0% $31.5M+14.3% $27.6M+0.2% $27.5M-1.0% $27.8M-0.1% $27.9M+11.2% $25.0M+0.2% $25.0M
Share Buybacks $25.1M-39.3% $41.3M+39.1% $29.7M-3.9% $30.9M-61.7% $80.7M+182.4% $28.6M+98.5% $14.4M $0

ARMK Financial Ratios

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Gross Margin 8.7%+0.1pp 8.6%+0.4pp 8.2%+0.2pp 8.0%-0.4pp 8.4%-0.4pp 8.8%-0.2pp 9.0%+1.3pp 7.7%
Operating Margin 4.5%-0.0pp 4.5%+0.2pp 4.3%+0.4pp 4.0%-0.1pp 4.1%-0.7pp 4.8%-0.2pp 5.0%+1.3pp 3.7%
Net Margin 2.1%+0.1pp 2.0%+0.3pp 1.7%+0.2pp 1.6%+0.1pp 1.5%-0.9pp 2.3%-0.5pp 2.8%+1.4pp 1.3%
Return on Equity 3.1%+0.1pp 3.0%+0.2pp 2.8%+0.4pp 2.3%+0.3pp 2.1%-1.4pp 3.4%-0.6pp 4.0%+2.1pp 2.0%
Return on Assets 0.7%+0.0pp 0.7%+0.1pp 0.7%+0.1pp 0.5%+0.1pp 0.5%-0.4pp 0.8%-0.1pp 1.0%+0.5pp 0.5%
Current Ratio 1.21-0.1 1.27+0.3 0.99-0.3 1.29+0.1 1.21+0.3 0.94+0.1 0.81-0.2 0.96
Debt-to-Equity 1.85-0.1 1.94+0.2 1.71-0.3 2.030.0 2.02+0.4 1.61+0.2 1.42-0.3 1.71
FCF Margin 6.1%+24.8pp -18.7%-39.2pp 20.5%+21.2pp -0.8%-4.0pp 3.3%+18.8pp -15.5%-35.5pp 20.0%+18.7pp 1.3%

Similar Companies

Frequently Asked Questions

Aramark US (ARMK) reported $18.5B in total revenue for fiscal year 2025. This represents a 6.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Aramark US (ARMK) revenue grew by 6.4% year-over-year, from $17.4B to $18.5B in fiscal year 2025.

Yes, Aramark US (ARMK) reported a net income of $326.4M in fiscal year 2025, with a net profit margin of 1.8%.

Aramark US (ARMK) reported diluted earnings per share of $1.22 for fiscal year 2025. This represents a 23.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Aramark US (ARMK) had EBITDA of $1.3B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Aramark US (ARMK) had $439.6M in cash and equivalents against $6.2B in long-term debt.

Aramark US (ARMK) had a gross margin of 8.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Aramark US (ARMK) had an operating margin of 4.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Aramark US (ARMK) had a net profit margin of 1.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Aramark US (ARMK) paid $0.42 per share in dividends during fiscal year 2025.

Aramark US (ARMK) has a return on equity of 10.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Aramark US (ARMK) generated $431.8M in free cash flow during fiscal year 2025. This represents a 44.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Aramark US (ARMK) generated $921.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Aramark US (ARMK) had $13.5B in total assets as of fiscal year 2025, including both current and long-term assets.

Aramark US (ARMK) invested $489.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Aramark US (ARMK) spent $169.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Aramark US (ARMK) had 263M shares outstanding as of fiscal year 2025.

Aramark US (ARMK) had a current ratio of 1.27 as of fiscal year 2025, which is considered adequate.

Aramark US (ARMK) had a debt-to-equity ratio of 1.94 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Aramark US (ARMK) had a return on assets of 2.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Aramark US (ARMK) has an Altman Z-Score of 2.46, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Aramark US (ARMK) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Aramark US (ARMK) has an earnings quality ratio of 2.82x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Aramark US (ARMK) has an interest coverage ratio of 2.2x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Aramark US (ARMK) scores 38 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top